Clinical Trial Update: Lipopolysaccharide (LPS) or Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Challenge Study on Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial assessing LPS or GM-CSF challenge in healthy subjects, with conditions including rheumatoid arthritis; completed with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) (sargramostim)
• Lipopolysaccharide (LPS) (lipopolysaccharide)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Arthritis, Rheumatoid | Phase 1 | Status: COMPLETED | Results posted: 2019-08-08